Recent research focusing on Semaglutide at a dosage of 30mg is shedding new light on its potential effects. Early findings suggest that this higher dosage may enhance the drug's ability to regulate blood glucose, potentially offering improved outcomes for individuals with type 2 diabetes. Further research is underway to fully evaluate the long-term